UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S692 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S312-S313

2021

Volltextzugriff (PDF)

Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First

Digestive diseases and sciences, 2024-08, Vol.69 (8), p.2725-2726

2024

Volltextzugriff (PDF)

A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease

Therapeutic advances in gastroenterology, 2022, Vol.15, p.17562848221127238-17562848221127238

2022

Volltextzugriff (PDF)

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy

Journal of Crohn's and colitis, 2013-03, Vol.7 (2), p.e42-e48

2013

Volltextzugriff (PDF)

Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database

United European gastroenterology journal, 2014-12, Vol.2 (6), p.505-512

2014

Volltextzugriff (PDF)

Vertebral Fractures and Role of Low Bone Mineral Density in Crohn’s Disease

Clinical gastroenterology and hepatology, 2007-06, Vol.5 (6), p.721-728

2007

Volltextzugriff (PDF)

Mo1727 High Incidence of TB in Large Hospital Database-Based Studies of IBD Patients in the Era of Biologics

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-671-S-671

2012

Volltextzugriff (PDF)

Mo1726 IBD Patients Have a Higher Rate of Femoral Neck Fractures: A Record-Linkage Study of English Hospital Admissions From 1999-2008

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-670-S-670

2012

Volltextzugriff (PDF)

Tu1297 A Record-Linkage Study of Maternal Perinatal Outcomes in Patients With Inflammatory Bowel Disease in Oxford, From 1970-1989

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-796-S-796

2012

Volltextzugriff (PDF)

Tu1301 Adult and Pediatric IBD Incidence in the UK: A Large Population-Based Study Using the General Practice Research Database

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-797-S-797

2012

Volltextzugriff (PDF)

Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease

Clinical gastroenterology and hepatology, 2005-02, Vol.3 (2), p.122-132

2005

Volltextzugriff (PDF)

S1022 Risedronate in Addition to Daily Calcium and Vitamin D Results in Improved Bone Mineral Density in the Femoral Trochanter in Treating Low Bone Mineral Density in Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-162-S-162

2010

Volltextzugriff (PDF)

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2020-06, Vol.158 (8), p.2139-2149.e14

2020

Volltextzugriff (PDF)

The frequency of vitamin D deficiency in adults with Crohn's disease

Canadian journal of gastroenterology, 2003-08, Vol.17 (8), p.473-478

2003

Volltextzugriff (PDF)

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

The Lancet (British edition), 2022-06, Vol.399 (10341), p.2113-2128

2022

Volltextzugriff (PDF)

Bones and Crohn's. Risk factors associated with low bone mineral density in patients with Crohn's disease

Inflammatory bowel diseases, 2004-05, Vol.10 (3), p.220-228

2004

Volltextzugriff (PDF)

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Journal of Crohn's and colitis, 2021-10, Vol.15 (10), p.1694-1706

2021

Volltextzugriff (PDF)

Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial

Digestive diseases and sciences, 2024-05, Vol.69 (5), p.1636-1648

2024

Volltextzugriff (PDF)

215 Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately-to-Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U-ACHIEVE

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S131-S131

2019

Volltextzugriff (PDF)

Tu1723 ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1094-S-1095

2023

Volltextzugriff (PDF)

S1217 Metabolomics in Inflammatory Bowel Disease: Differentiating Patients with or Without IBD

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-203-A-203

2008

Volltextzugriff (PDF)

Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

Clinical gastroenterology and hepatology, 2024-10, Vol.22 (10), p.2096-2106

2024

Volltextzugriff (PDF)

STRICTURE DILATION VIA BALLOON-ASSISTED ENDOSCOPY IN SMALL BOWEL CROHN'S DISEASE: INTRAPROCEDURAL OUTCOMES AND COMPARISON OF THE SINGLE BALLOON AND DOUBLE BALLOON SYSTEMS

Gastrointestinal endoscopy, 2022-06, Vol.95 (6), p.AB104-AB105

2022

Volltextzugriff (PDF)

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease

The New England journal of medicine, 2024-07, Vol.391 (3), p.213-223

2024

Volltextzugriff (PDF)

Treatment patterns for advanced therapies in Canadians with moderate-to-severe inflammatory bowel disease: a retrospective cohort analysis

Journal of the Canadian Association of Gastroenterology, 2024-10

2024

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)
magazinearticle
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

S692 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study

Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First

A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease

Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy

Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database

Vertebral Fractures and Role of Low Bone Mineral Density in Crohn’s Disease

Mo1727 High Incidence of TB in Large Hospital Database-Based Studies of IBD Patients in the Era of Biologics

Mo1726 IBD Patients Have a Higher Rate of Femoral Neck Fractures: A Record-Linkage Study of English Hospital Admissions From 1999-2008

Tu1297 A Record-Linkage Study of Maternal Perinatal Outcomes in Patients With Inflammatory Bowel Disease in Oxford, From 1970-1989

Tu1301 Adult and Pediatric IBD Incidence in the UK: A Large Population-Based Study Using the General Practice Research Database

Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease

S1022 Risedronate in Addition to Daily Calcium and Vitamin D Results in Improved Bone Mineral Density in the Femoral Trochanter in Treating Low Bone Mineral Density in Patients With Crohn's Disease

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

The frequency of vitamin D deficiency in adults with Crohn's disease

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Bones and Crohn's. Risk factors associated with low bone mineral density in patients with Crohn's disease

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial

215 Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately-to-Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U-ACHIEVE

Tu1723 ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICS

S1217 Metabolomics in Inflammatory Bowel Disease: Differentiating Patients with or Without IBD

Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

STRICTURE DILATION VIA BALLOON-ASSISTED ENDOSCOPY IN SMALL BOWEL CROHN'S DISEASE: INTRAPROCEDURAL OUTCOMES AND COMPARISON OF THE SINGLE BALLOON AND DOUBLE BALLOON SYSTEMS

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease

Treatment patterns for advanced therapies in Canadians with moderate-to-severe inflammatory bowel disease: a retrospective cohort analysis

Suchergebnisse filtern